Na Yeon Kim serves as Executive at NeuroBo Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Na Yeon Kim has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 27, 2023 involved receiving (via award) 87,500 shares valued at $0.
Na Yeon Kim currently holds 88,959 shares of NeuroBo Pharmaceuticals, Inc. (NRBO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Na Yeon Kim has been a net neutral trader of NRBO stock. They have purchased $0 and sold $0 worth of shares.
Na Yeon Kim's most recent insider trade was on Jul 27, 2023, when they sold 87,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 26, 2022 | NRBO | $0 | Other | 4,671 | $N/A | Discretionary |
| Jul 26, 2022 | NRBO | $0 | Other | 1,445,267 | $N/A | Discretionary |
| Dec 30, 2019 | NRBO | $0 | Award | 1,121,190 | $N/A | Discretionary |
| Dec 30, 2019 | NRBO | $0 | Award | 4,335,800 | $N/A | Discretionary |
| Dec 30, 2019 | NRBO | $0 | Award | 1,864,799 | $N/A | Discretionary |